ArticleJMIR research protocols2019

VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies.

Laura Beaton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.